The dog is recognized as a highly predictive model for preclinical research. Its size, life span, physiology, and genetics more closely match human parameters than do those of the mouse model. Investigations of the genetic basis of disease and of new regenerative treatments have frequently taken advantage of canine models. However, full utility of this model has not been realized because of the lack of easy transgenesis. Blastocyst-mediated transgenic technology developed in mice has been very slow to translate to larger animals, and somatic cell nuclear transfer remains technically challenging, expensive, and low yield. Spermatogonial stem cell (SSC) transplantation, which does not involve manipulation of ova or blastocysts, has proven to be an effective alternative approach for generating transgenic offspring in rodents and in some large animals. Our recent demonstration that canine testis cells can engraft in a host testis, and generate donorderived sperm, suggests that SSC transplantation may offer a similar avenue to transgenesis in the canine model. Here, we explore the potential of SSC transplantation in dogs as a means of generating canine transgenic models for preclinical models of genetic diseases. Specifically, we i) established markers for identification and tracking canine spermatogonial cells; ii) established methods for enrichment and genetic manipulation of these cells; iii) described their behavior in culture; and iv) demonstrated engraftment of genetically manipulated SSC and production of transgenic sperm. These findings help to set the stage for generation of transgenic canine models via SSC transplantation. Reproduction (2013) 146 75-90 
Introduction
Spermatogonial stem cells (SSC) are the stem cells in testis that generate spermatozoa throughout the adult life of the males. As with all true stem cells, SSC can undergo both self-renewal and differentiation divisions, thereby maintaining a static population of stem cells, while generating a constant supply of spermatozoa. In mice, these cells can be isolated and expanded indefinitely without genetic drift or loss of stem cell potential (Shinohara & Brinster 2000 , Shinohara et al. 2000a , 2000b , Kanatsu-Shinohara et al. 2003 , Nagano et al. 2003 , Kubota et al. 2004 , Hamra et al. 2005 , Oatley & Brinster 2006 , Oatley et al. 2010 . They can be genetically manipulated efficiently by transduction and transfection (Kanatsu-Shinohara et al. 2004 , Hamra et al. 2005 , Takehashi et al. 2010 . SSC provide an alternative approach for the generation of transgenic mice. When transplanted into the testes of sterile male mice, SSC efficiently repopulate the seminiferous tissue and reinitiate spermatogenesis. The offspring of these males carry the genetic properties of the donor cells (Kanatsu- Shinohara et al. 2004 , KanatsuShinohara & Shinohara 2007 , Takehashi et al. 2010 . Mouse SSC can also be converted into pluripotent cells, without genetic manipulation (Guan et al. 2006 , Conrad et al. 2008 , Izadyar et al. 2008 , Golestaneh et al. 2009b , Mizrak et al. 2010 . These germ-line-derived pluripotent stem cells (gPS) acquire an expression profile similar to embryonic stem cells (ESCs; Silva et al. 2009 ) and are functionally indistinguishable from ESC: they form complex teratomas, differentiate into three germ layers in culture, and contribute to all the tissues of mice generated from chimeric blastocysts (Takehashi et al. 2007 , Conrad et al. 2008 , Izadyar et al. 2008 . Thus, at least in the mouse, SSCs provide an unusually versatile source of material for stem cell and developmental research, including transgenic animal technology and stem cell-based cell therapy.
It would be extremely valuable to translate this technology to large animals for modeling human diseases. The SSC could be used directly to generate transgenic animal models for preclinical research, and the gPS would serve to bypass both the ethical concerns regarding ESC and the potential of genetic anomalies created in the multi-gene insertion approaches to generating 'induced PS' (iPS) cells. Other approaches to transgenic models in large animals have been very difficult and inefficient. While multiple lines of canine (Hayes et al. 2008 , Wilcox et al. 2009 ) and other large animal (Kumar De et al. 2011 , Vassiliev et al. 2011 , Kim et al. 2012 ESCs have been reported, all non-rodent lines tend to show genetic drift and loss of pluripotency over time (Yang et al. 2010 , Gerwe et al. 2011 . In addition, demonstration of germ-line transmission and generation of transgenic large animal models from ESC have been largely unsuccessful. Genetically, chimeric pigs have been produced recently (West et al. 2010) by implanting iPS into early embryos, but this approach has not yet succeeded in other large animals. Several transgenic dogs (Hong et al. 2009 (Hong et al. , 2011 and other large animal models , Giraldo et al. 2012 , Jung et al. 2013 ) have been generated through somatic nuclear transfer but, so far, this approach has been extremely labor, cost, and animal intensive.
Several authors have reported isolation and short-term culture of spermatogonia (SPG) from large animals (Kim et al. 2006 , Rodriguez-Sosa et al. 2006 , Goel et al. 2007 , Hermann et al. 2007 , Aponte et al. 2008 and humans (Wu et al. 2009a) , as well as conversion of these cells into gPS cells (Golestaneh et al. 2009b) . SSC transplantation and subsequent donor sperm production has now been reported in pigs, sheep, bulls, goats, monkeys, and dogs (Izadyar et al. 2003 , Kim et al. 2008 , Herrid et al. 2011 , Jahnukainen et al. 2011 , Hermann et al. 2012 , Zeng et al. 2012 . More importantly, SSC transplants in both sheep (Herrid et al. 2009 ) and goats (Honaramooz et al. 2003) have led to the birth of donorderived offspring through normal mating. So this technology is clearly applicable to large animals.
In this light, the canine has major potential as a preclinical transgenic model for two major reasons. First, research with the canine model has proven to be highly translatable to the clinical setting. This model better reflects the size, life span, physiology, and genetics of humans than does the mouse model (Tsai et al. 2007 ). The canine model is also much more cost-effective than primate models. It is a primary preclinical model for hematopoietic stem cell transplantation (Lupu & Storb 2007) , gene therapy (Nowend et al. 2011 , Okazuka et al. 2011 , and cancer research (Gordon & Khanna 2010 , Rowell et al. 2011 . The dog displays a large repertoire of naturally occurring genetic diseases with human counterparts (Athanasiou et al. 1995 , Lingaas et al. 2003 , Acland et al. 2005 , and where data are available, the same genes are involved in both species (Tsai et al. 2007) . Secondly, the ability of canine SSC to engraft and reinitiate spermatogenesis in a recipient testis has been demonstrated (Kim et al. 2008) . So far, canine SSC activity has only been shown in freshly prepared, unfractionated testis cells. It remains to be demonstrated that canine SSC can retain engraftment potential after purification, genetic manipulation, culture, and cryopreservation.
Here, we describe, for the first time, the identification, isolation, culture, and genetic manipulation of canine SSC. We demonstrate engraftment and generation of mature transgenic sperm by canine SSC transplanted into the testes of recipient males. A true SSC can only be distinguished from committed and differentiating SPG by its ability to engraft. Therefore, the term 'SSC' will be reserved henceforth for true stem cells, while the more general term 'SPG' will be used when that distinction is not verifiable.
Materials and methods

Reagents
Hanks' balanced salt solution (HBSS; cat #14175), penicillin/streptomycin (15140-122), B27-vitamin A supplement (12587-010), trypsin-EDTA (25200-056), Superscript II reverse transcriptase (18064-014), all Alexa-tagged secondary antibodies (Supplementary  Table 1 ), dispase (17105-041), dispase (17105-041), mouse LIF (LIF2005), and heat-inactivated FBS (10082147) were from Invitrogen. Biosprint 96 blood DNA isolation kits (940057), and RNAeasy RNA isolation mini kits (74104) were from Qiagen. Type 4 collagenase (LS004212) and hyaluronidase (LS005475) were from Worthington (Lakewood, NJ, USA). Primary antibodies were purchased as indicated in Supplementary Table 1 . DMEM/F12 medium (SH30023.01) and buffered formalin (SF98-4) were from Fisher Scientific (Waltham, MA, USA). Primer synthesis was done by Operon (Huntsville, AI, USA). Trypsin (T4799), DNase I (D4513-1VL), laminin (L2020), gelatin (G1890-100G), L-glutamine (G6392-10L), BSA (A9576-50ml), donkey serum (D9663-10ML), and human FGF2 (F0291-25UG) were from Sigma. Advantage 2 polymerase mix (639202) was from Clontech. Human EGF (354052) was from BD Biosciences (San Jose, CA, USA). Human GDNF (212-GD-050) was from Roche Biochemicals. Rat soluble GFRA1 (560-GR-100), human BDNF (284-BD-025), human NT3 (267-N3-025), human NT4 (268-N4-025), human , and human WNT3A (5036-WIN-010) were from R&D Systems (Minneapolis, MN, USA).
Target retrieval solution (S1699) was from DAKO (Carpinteria, CA, USA). Falcon tissue culture flasks and plates were from BD Biosciences.
Canine testis tissues
Testes were obtained from the Seattle Spay and Neuter Clinic immediately following routine neutering for unrelated purposes. Tissue was collected from a variety of breeds in the age range of 3-12 months. Testes were transported in sterile Hanks buffered saline on ice and used within 2 h of castration.
Isolation and culture of SPG
Testes from 3-to 5-month-old (prepubertal) dogs were washed twice in fresh, sterile HBSS. The testis parenchyma, containing the testicular cords, was dissected away from the tunica vaginalis and tunica albuginea, epididymis, and other non-seminiferous tissue, washed twice in HBSS, minced to !1 mm pieces, and digested for 30 min at 37 8C in 30 ml DMEM/F12 medium containing 1 mg/ml type 4 collagenase and 33 mg/ml DNase I. Tissue was dispersed into single cells and small lengths of cords by vigorous pipetting and then filtered through sterile gauze. The filtrate was washed twice in HBSS by centrifugation at 200 g for 5 min. The washed cells and cord segments were plated in 225 cm 2 culture flasks at an estimated 5!10 7 cells/flask in DMEM/F12 medium containing 10% FBS, 50 units/ml penicillin, and 50 mg/ml streptomycin. At 3 days of culture, dead cells were removed by replacing the medium with HBSS. Loose cells were then dislodged from the tissue culture layer by 15-20 vigorous horizontal raps of the flask against a styrofoam block. The loose cells were pooled and selected for non-adhesion to gelatin by two rounds of plating for 2 h on a gelatin-coated 10 cm tissue culture dish and re-collection of all non-adherent cells. The remaining loose cells were either used directly for analysis or cryopreserved under liquid nitrogen in 70% DMEM/F12, 20% FBS, and 10% DMSO. Cells were cultured in either of two basic media: i) complete DMEM/F12: DMEM/F12 with 10% FBS and Pen/Strep or ii) SG: a serum-free medium optimized for rat SSC culture (Wu et al. 2009b) . Additional modifications to the culture conditions, including substratum, feeder cells, serum level, and growth factors, are specified in Supplementary Table 2, see section on supplementary data given at the end of this article. Mouse embryonic feeder cells were expanded from 14-day mouse embryos, mitotically inactivated by g irradiation (3000 Rad), and plated at 25 000 cells/cm 2 1 day before addition of SPG. Testis fibroblast feeder cells were adherent cells from 3-month-old canine testis, expanded for at least three passages, and at least 10 days of constant culture, then irradiated at 3000 Rad, and plated at 25 000 cells/cm 2 1 day before addition of SPG. Cultures were maintained at 37 8C in a humidified tissue culture incubator with 5% CO 2 and media were changed every 48 h.
Lentiviral constructs
Self-inactivating lentiviral reporter construct, PL-SINEF1a-EGFP (Hotta et al. 2009 ), driven by the widely expressed mouse EF1a promoter, was purchased from Addgene (http://www.addgene.org). A second selfinactivating lentiviral construct carrying a widely expressed PGK-mCherry reporter (pRCH-PCh-W) was obtained from the Viral Vector Production Core at Fred Hutchinson Cancer Research Center. Packaging vector, psPAX2 (plasmid 12260) and vsv-G envelope vector, pMD2.G (plasmid 12259), were from the Trono Lab and purchased from Addgene (http://www.addgene. org/Didier_Trono).
Lentiviral transduction of SPG
PL-SIN-EF1a-EGFP and pRCH-PCh-W were packaged in HEK293 cells as VSVG-pseudotyped lentiviral particles according to Addgene protocol E.2, filtered through a 0.45 mM filter (Millipore, Billerica, MA, USA), concentrated by centrifugation at 13 000 g for 15 h, and stored in aliquots at K80 8C. Infectious particle concentrations were determined by titered infection of HEK293 cells (15-h transduction in the presence of 4 mg/ml polybreen on 70% confluent cells), followed by determination of percentage of reporter-expressing cells at 48 h postinfection. Final titers were 1-2!10 7 infectious units/ml. Transduction of freshly isolated SPG (loose cells) was performed by incubating 0.5-2!10 6 cells with virus (MOIZ5-15) in 1 ml transduction medium (DMEM/F12/ 10%FBS/4 mg/ml polybreen) for 15 h in a tissue culture incubator. Cells were then washed twice with HBSS and plated in SG medium. Expression of reporter genes was monitored by flow cytometry and by epifluorescence microscopy.
Histology and immunohistochemistry
Seminiferous tissue was cut into 1 cm cubes, fixed for 72 h in buffered formalin, embedded in paraffin, and sectioned at 1.5 mm thickness. Sections were deparaffinized in three washes of xylene, rehydrated through an ethanol series (100, 100, 85, 70%, and water), and washed twice in TBST (50 mM Tris, 150 mM NaCl, and 0.1% Tween 20, pH 7.6) for 10-min intervals. Antigen retrieval was performed by a 20-min incubation at 95 8C in a pre-warmed target retrieval buffer (DAKO) followed by three washes in HBSS. Treated sections were incubated for 30 min in blocking buffer (TBSTC5% BSA and 5% Donkey serum) and then for 15 h at 4 8C in Table 1 ) in TBST, washed similarly, and observed by epifluorescent microscopy. Cultured cells were fixed on the plate for 20 min in 10% buffered formalin and probed as described for post-antigen retrieval sections. DBAmediated localization of a-D-N-acetyl-galactosamine was performed as described (Izadyar et al. 2002) .
Microscopy
Phase and epifluorescent microscopy were done on an Eclipse Ti-U inverted microscope equipped with several phase lenses, a TI-FL Epi-fl epi-illumination system, and digital DS-Qi1Mc monochrome camera (Nikon). Images were recorded and pseudo-colored using NIS-Elements D3.2 Software from Nikon and color-merged with Photoshop Software (Adobe).
Flow cytometry analysis
For dual reporter expression studies, cells were washed twice with HBSS, dissociated with trypsin-EDTA for 5 min at room temperature, washed twice with HBSS, and observed by flow cytometry on a FACS Calibur flow cytometer (BD Biosciences). For comparison of GFP reporter expression to VASA immunolocalization, cells were washed twice with HBSS, dissociated with trypsin-EDTA for 5 min at room temperature, fixed for 5 min in 10% buffered formalin, washed three times in HBSS, blocked 10 min in blocking buffer, incubated at RT for 1 h in blocking buffer containing anti-VASA antibody (Supplementary Table 1) at 100! dilution, re-washed and incubated with donkey anti-rabbit-Alexa-594 secondary antibody (Supplementary Table 1) , rewashed, and observed by flow cytometry as earlier. All washes were performed by re-suspension in HBSS and centrifugation at 200 g for 5 min.
RT-PCR analysis of gene expression
Three separate experiments were performed using dissociated testicular cells from three different prepubertal dogs: a 16-week-old Black Labrador and two 10-week-old German Shepherd littermates. For each testis sample, RNA was extracted from intact seminiferous tissue at day 0, from the total cultured cells at 3 days, from the 'loose' and adherent cell populations isolated at day 3, and from duplicate loose and adherent populations after 30 days in culture. RNA from testis tissue and cultured cells was extracted using an RNeasy mini kit (Qiagen) according to the manufacturer's instructions and quantitated by u.v. spectral analysis using a Nanodrop 1000 spectrophotometer (ThermoFisher Scientific, Inc., Wilmington, DE, USA). Two micrograms of RNA were reverse transcribed using oligo-dT18 primers and Superscript II Reverse Transcriptase (Invitrogen) according to the manufacturer's instructions. Before expression analysis, cDNAs were normalized to b-actin (ACTB) by adjusting the cDNA concentrations until they gave similar signals by ACTB RT-PCR. The adjusted cDNAs were used for all subsequent expression analysis. Primers for amplification of each specific mRNA target (Supplementary Table 3 , see section on supplementary data given at the end of this article) were designed to amplify a region spanning one or more introns of significant size, thus eliminating false-positive signals from contaminating genomic DNA. Each primer pair was verified by cloning and sequencing the product amplified from testis cDNA. Primers were designed with a Tm of 72-74 8C to accommodate a uniform two-step cycle of 20 s at 94 8C and 2 min at 68 8C. Amplifications were performed as 20 ml reactions containing 2 ml normalized cDNA, primers at 200 nM, dNTPs at 200 mM, and Advantage 2 polymerase mix and buffer. Products were separated by agarose, gel electrophoresis, and detected by ethidium bromide staining. Table 4 ) were prepared and transduced with lentivirus, as described earlier, washed in serum-free and growth factor-free SG medium, and cryopreserved in SG/20% BSA/10% DMSO. On the day of transplantation, each cell preparation was thawed, washed three times in DMEM/F12, re-suspended in 1 ml DMEM/F12, and held at 4 8C until use (1-3 h). Transplantation of SPG and all animal care and handling were done at Cornell University, and all related protocols were reviewed and approved by the Institutional Animal Care and Use Committee of Cornell University. Three 5-month-old hounds (Marshall BioResources, North Rose, NY, USA) had their testes subjected to focal external beam radiation to deplete their endogenous germ cells as described (Kim et al. 2008) , except that the irradiation regimen was reduced from three consecutive days of 3 Gy/day, 8 weeks before transplant, to a single 3 Gy dose on the day of transplant. The smaller dose was designed to lower the apparently excessive toxicity to the testis tissues observed in our previous study, which had resulted in complete loss of libido and almost no recovery of testis size, histological evidence of spermatogenesis, or sperm count. One milliliter of medium containing 2-5!10 5 SPG was injected in retrograde fashion into the rete testis under the guidance of ultrasound scanning (Aloka 633, Colormetrics Medical Systems, Inc., Wallingford, CT, USA) as described previously (Kim et al. 2008) .
Transplantation of SSC
Several preparations of donor SPG (Supplementary
VNTR analysis of donor/recipient sperm production DNA was purified by silica binding from ejaculated sperm, using a Qiagen Biosprint magnetic bead DNA isolation kit, according to the manufacturer's instructions. Donor and recipient DNA standards were prepared respectively from testis tissue used to generate each SSC preparation and blood from pretransplant recipients. The contribution of recipient and donor sperm cells was quantified by fluorescent VNTR analysis of microsatellite loci, as described (Scharf et al. 1995 , Hilgendorf et al. 2005 and modified (Graves et al. 2007) . Microsatellite FH2001 was used to distinguish the DNA of recipients 795941 and 795917 from their respective donor cells. Microsatellites FH2611 and FH2199 were used to distinguish Recipient 795933 from its donor cells. The primers used for these VNTRs are listed in Supplementary 
Results
Establishment of molecular markers for canine SPG
In order to identify and track canine SPG in culture, we screened a battery of commercially available antibodies to established murine and human SPG markers for specificity in canine prepubertal (4 months) testis. At this stage, the testicular cords present a simple architecture compared with mature testis (Nayernia et al. (2004) ; see Fig. 1A ). Only two cell types, the gonocytes/SPG and Sertoli cells, are packed in the dense cord-like structures bound by a basement membrane. Both cell types are attached to the basement membrane at this age, but the Sertoli cell nuclei align along the periphery while the nuclei of the SPG are more centrally located (Nayernia et al. 2004) . All SPG are SSC at this stage, as spermatogenesis has not yet started. Antibodies against reported SPG and SSC-specific target antigens VASA (Noce et al. 2001) , UCHL1 (Goel et al. 2007) , DAZL (Anderson et al. 2007) , PLZF (Jijiwa et al. 2008) , AP180 (von Kopylow et al. 2010), POUF5 (Anderson et al. 2007) , and RET (Anderson et al. 2007 , Tyagi et al. 2009 ) marked the interior SSC of canine prepubertal testis (Fig. 1) . In contrast, ACTA1 was enriched outside of the cords in peri-tubular myoid and Leydig cells (Fig. 1B, C , D, E, F, G, H and I). GATA4, known as a Sertoli cell marker in mice (Ketola et al. 2002) and pigs (McCoard et al. 2001) , was confined to the peripheral Sertoli nuclei of the cords (Fig. 1J, K and L) . The VASA antibody was the most reliable probe for SSC, yielding a consistent, strong signal in all experiments. Dual-label staining demonstrated co-localization of VASA, UCHL1, DAZL, PLZF, and AP180 in the same set of interior cells (Supplementary Figure 1 , see section on supplementary data given at the end of this article). Unfortunately, we were unable to demonstrate SSC-specific labeling by antibodies against established murine SSC surface antigens (data not shown), such as GFRA1, B1 and A6 integrins, and GPR125, each of which could be useful for immunofluorescent sorting of mouse SSC (Shinohara et al. 1999 , Bjarnadottir et al. 2004 , Grisanti et al. 2009 ). Localization of cRet, another SPG surface antigen in mice (Tyagi et al. 2009 ), was sporadic in prepubertal canine testis and appeared to be nuclear rather than cell surface (Fig. 1G) . The reported localization of a-D-N-acetyl-galactosamine on the surface of porcine (Goel et al. 2007 ) and bovine (Izadyar et al. 2002 ) SSC could also not be confirmed in the dog using a similar dolichos biflorus agglutinin (DBA) binding assay.
The same probes were used to localize SPG in mature testis (Fig. 2) . As the testis matures, a central lumen forms in the cords, creating seminiferous tubules. The SSCs are confined at the basement membrane by Sertoli cells. Successive advancing stages of male germ cell development (SPG, spermatocytes, spermatids, and spermatozoa) advance spatially toward the lumen, whereas Sertoli cell processes interdigitate among the male germ cells, supporting the developmental process (Nayernia et al. (2004) ; see Fig. 2A ). Most of the SPG/SSC markers seen in prepubertal testis were more difficult to detect in mature testis. All immunofluorescence signals were lower in adults. However, VASA, UCHL1, and DAZL were clearly expressed in cells located either at the basement membranes of tubules, or in layers near these peripheral cells (Fig. 2B , C, D, E and F), consistent with SPGs and early stages of spermatogenesis. As detected by immunohistochemistry, VASA expression appeared to be higher in differentiating SPGs and spermatocytes than in the most peripheral cells, including the SSC (see Supplementary Figure 4 , see section on supplementary data given at the end of this article). This pattern is similar to that seen in Human and Rhesus testis (Castrillon et al. 2000 , Hermann et al. 2007 ). Thus, VASA may be a poor marker for adult canine SSC and a clear marker has not yet emerged. As indicated in Fig. 2E and F, DAZL and UCHL1 may detect earlier stages than VASA, but the identity of the positive cells is not yet clear.
Isolation of canine SSC
Prepubertal testes (3-6 months) were used as the source of SSC, taking advantage of the lower cellular complexity of the tissue at this stage. Spermatogenesis has not yet begun, and SSC are the only germ-lineage cells in the testes. In contrast to the mouse, a standard two-step digestion of canine prepubertal testis tissue with collagenase, followed by collagenase plus trypsin, and/or hyaluronidase (Hamra et al. 2008) did not generate a usable single-cell suspension. Considerable cell lysis was observed within the cords before the basement membrane dissociated. Thus, we chose a gentler collagenase-only digestion and plated incompletely digested pieces of seminiferous cords (Fig. 3A) . By 3 days, most cells had migrated out of the cord structures onto the plate surface. Most of the VASAC cells were rounded, loosely adherent cells that resided on top of a super-confluent layer of fibroblast-like cells ( Figs 3B and C, 4A ). These VASAC cells could be dislodged by vigorous agitation of the flask and harvested with the medium. The 'loose' cells were then further enriched by depleting collagen-adhesive cells (Hamra et al. 2008) , with two rounds of short-term culture on gelatin-coated plates. The final preparation typically contained about 0.5-1!10 6 of 70% pure SPG, as judged by VASA immunohistochemistry (Fig. 4B) and by flow cytometry (Fig. 4C) . Before enrichment, !3% of cells were VASA-positive, indicating an enrichment of about 23-fold. Cryopreservation of the enriched cells, followed by thawing and washing, resulted in about 70% viability, based on trypan blue exclusion. RT-PCR analysis of several SPG markers confirmed the enrichment of SPGs (Fig. 4D) . Canine homolog mRNAs of the well-established mouse SPG markers, DAZL, AP180, Putative SPG marker RNAs, GFRA1, GPR125, ITGA6, and ITGB1, did not enrich with the canine SPGs, consistent with the lack of SPG-specific localization of the respective antigens by immunohistochemistry in canine testis (above). In addition UCHL1 mRNA was not enriched in the SPG pool, consistent with a posttranscriptional regulation in germ cells, or perhaps upregulation of the gene in cultured adherent cells as reported previously (Luo et al. 2006) .
Gene transfer into canine SPG
To test the efficiency of gene transfer by lentivirus, freshly enriched SPG were transduced with lentiviral vectors containing either an EF1-GFP or a CMV-mCherry reporter and analyzed by flow cytometry for reporter expression. When cells were transduced with both vectors, at a multiplicity of infection (MOI) of five each and analyzed at 48 h ( Fig. 5A and B) about 32% of the cells expressed at least one reporter and 22% expressed both. As fibroblasts tend to rapidly out-grow the SPG in these cultures, a second experiment focused on reporter expression within the VASAC population. Cells were transduced at an MOI of 20 with the EF1-GFP reporter vector, then fixed, permeabilized, and labeled with the VASA antibody at 96 h for flow cytometry (Fig. 5C) . The SPG population (retaining VASA expression) showed a transduction efficiency of 8.8% under the conditions used here, based on GFP expression. Thus, it is possible to insert and express transgenes in these cells by standard lentiviral transduction at a significant level. Our data might underestimate the true transduction efficiency of SPG if a portion of the cells left the VASAC pool (differentiated or died) during the incubation period. 
Behavior of canine SPG in culture
Conditions for in vitro survival and expansion of rodent SSC have been extensively studied, suggesting appropriate conditions to try for canine SPG culture. The essential factor for self-renewal-type expansion of rodent SSC in culture is glial cell-derived neurotrophic factor (GDNF; Oatley et al. 2006) . However, EGF and bFGF and LIF enhance the proliferative effect of GDNF (Kanatsu- Shinohara et al. 2003) . The inositol phosphateanchored GDNF co-receptor, GFRa1, which can be added effectively as a soluble agent, is essential in some strains of mice, suggesting that it is a limiting factor in those strains (Kubota et al. 2004 (Soh et al. 2007) , and Wnt3a (Golestaneh et al. 2009a) , have been implicated as having facilitating roles in survival and/or selfrenewal, either in SSC directly or in the closely related ESC. Both serum levels and feeder cells have had mixed effects on SSC survival in the literature (Hamra et al. 2005) . Matrix components, particularly laminin and collagen, are predicted to affect morphology, mobility, and regulation of SSC, based on the localization of these materials at the SSC niche, high levels of B1 and A6 integrins on SSCs, and an affinity for laminin (Shinohara et al. 1999) .
In an attempt to establish an optimal culture environment for canine SSC, the enriched cells were cultured under a variety of conditions (Supplementary  Table 1 , see section on supplementary data given at the end of this article). Base conditions were either a serumfree medium (SG), optimized for murine SSC culture (Wu et al. 2009b) , or DMEM/F12 with 10% fetal bovine serum (FBS). Additional variables included feeder cells (canine, murine, and none), substratum (laminin, gelatin, and none), altered serum content (10, 1%, and none), and a variety of growth factors implicated in the mouse literature as promoters of SSC self-renewal. As an initial criterion for successful SPG culture, we recorded presence or absence of VASA-positive cells after 1 month in culture. As seen in Supplementary Table 1, all culture conditions that included the established required components for rodent SSC self-renewal (SG medium with GDNF, FGF2, EGF, soluble GFRA1, and LIF; Wu et al. 2009b ) maintained significant numbers of VASA-positive cells for at least a month (e.g. Fig. 6E ). The individual components of this cocktail were not tested separately. Addition of feeder cells, matrix, or any of the other signaling molecules did not noticeably alter the number, staining intensity, morphology, or association of VASA-positive cells, as determined by microscopic observation over a 1-month period. Therefore, all subsequent studies used culture condition #12 (SG medium with GDNF, FGF2, EGF, soluble GFRA1, LIF, and a laminin substratum).
In early cultures, most of the cells adhered to substratum but maintained a relatively rounded morphology compared with the elongated fibroblastlike cells in the culture (Fig. 6A and B) . The rounded cells were often arrayed as connected chains, reminiscent of the syncytial chains of type A-aligned SPG in vivo (Hermann et al. 2009 ). By 8 days, fibroblasts had proliferated to form a confluent layer, and the lessadherent SPG-derived cells had formed irregular flattened clumps on top of the fibroblasts (Fig. 6C) . These clumps retain VASA expression for many weeks, as shown in Fig. 6D and E, and remain distinct from the rapidly expanding somatic cell population (Supplementary Figure 2 , see section on supplementary data given at the end of this article). Similar clumps of cells with similar morphology expressed several SPG markers in culture, including DAZL, UCHL1, and AP180 as well as VASA, all localized to similar clumps of cells with similar rounded morphology and round nuclei (Fig. 6F,  G, H and I) . The level of expression of a given marker varied significantly among members of the same clump (Fig. 6D) , and the relative expression of different SPG markers varied among closely associated cells in the clumps (Fig. 6J and K) . This might reflect varying stages of spermatogonial differentiation, as is the case in mature testis (see Fig. 2E ). In fact, over 2 weeks of culture, cells expressing DAZL, UCHL1, or AP180 became relatively rare, while VASA-positive cells remained numerous (data not shown). The germ-line-specific mRNA expression profiles seen at the time of isolation was lost by 30 days (Supplementary Figure 3) , consistent with the rapid expansion of somatic cells, and the probable loss of SPG over this period.
Although the marker-positive canine cells persisted for extended periods in culture, we have not yet been able to establish proliferating (non-differentiating) lines using available human and mouse growth factors. In one experiment, a set of replicate plates from a single SPG preparation was cultured without passage for 30 days. Plates were fixed and stained for VASA at intervals and the VASAC cells manually counted. There was no detectable loss or expansion of VASAC cells over this experiment. So far, any attempt to passage SPG clumps or entire populations leads to rapid loss of expression of the SPG markers.
Transplantation of genetically manipulated SPG and production of transgenic sperm
The only rigorous way to verify that the isolated 'loose' cells were SSC and that these cells retained true SSC characteristics after genetic manipulation is to demonstrate engraftment and donor spermatogenesis after transplantation into a host testis. To this end, six separate SPG preparations were transplanted into six recipient testes of three hounds. Four of the transplants used cells that had been previously transduced with a retroviral reporter (see Supplementary Table 4 , see section on supplementary data given at the end of this article). Recipient hounds were prepared by focal irradiation of the testes, and 2-5!10 5 SPG were injected into the seminiferous tubules of each testis via retrograde injection into the rete testis. Owing to the low recovery of spermatogenesis, and complete lack of libido observed in previous transplants (Kim et al. 2008) , the irradiation dose in this study was reduced from 3 days of 3 Gy/day to a single dose of 3 Gy.
Post-procedure, the recipient dogs showed normal sexual maturation, including normal-sized testes, normal libido, and interest in female urine. They also trained easily for manual ejaculation, allowing for periodic collections of sperm. Upon castration at 14 months post-transplant, the testis histology showed normal spermatogenic activity throughout the seminiferous tissue (Supplementary Figure 4) . Epidydimal sperm content, determined at the time of castration, was in the normal range, varying from 1.1-4.6!10 8 cells in the two dogs that received transgenic SPG (Supplementary Table 4) . Sperm samples were analyzed for donor DNA contribution at 4 months by variable number tandem repeat (VNTR). In replicate reactions, each animal showed donor signals at or near the threshold of detection (1% donor) by VNTR assay (e.g. Fig. 7A ). Standard curves for donor chimerism indicated no reliable quantitative information below 1% due to random noise. Similar equivocal VNTR evidence for donor sperm was obtained through 15 months posttransplant (data not shown). Thus, donor contribution in these dogs remained at or below 1% and could not be accurately quantified by this method.
As a more sensitive alternative assay, sperm DNA was analyzed for the presence of the reporter vector, PL-SINEF1a-EGFP, by PCR in the two animals that received transgenic SPGs. As shown in Fig. 7B , three separate PCR, amplifying three regions of the vector, were performed in parallel for internal verification. Both dogs yielded vector-positive sperm (Fig. 7C ) by this assay, while sperm from the non-transduced dog was negative. Based on the included vector standards, the copy number was between 20 and 60 copies/40 000 haploid cells. If we assume a vector copy number of 40/ 40 000 cells, an SPG transduction efficiency of 9% (shown above) and a vector copy/cell value of 1 (predicted from the low transduction efficiency), then we can estimate that about 0.1% of the total sperm were transgenic and that about 1.0% were of donor origin. This calculated figure was consistent with our VNTR results, showing positive signals at the 1% detection threshold.
Discussion
Our long-term goal is to develop a robust strategy for generating transgenic canine models. Traditional approaches to transgenics have focused on introducing transgenes either directly into oocytes and zygotes or indirectly into early embryos via replacement of inner cell mass cells with ESC or cloned cell. These approaches require the ability to harvest significant numbers of oocytes or embryos from the female reproductive tract, manipulate them in vitro without damage, and implant them efficiently into a surrogate mother. The difficulties in performing these tasks, the low yields and high costs of traditional cloning, and the absence of clear cut, genetically stable ESCs in most species combined to make development of transgenesis in large animal models a very expensive and time-consuming endeavor. The development of SSC transplantation in rodents, as an alternative to embryomediated gene transfer, opened a new opportunity to explore this relatively less invasive, more efficient and lower cost approach in canines and other larger animal models. Successful SSC transplantations in several large animals (Izadyar et al. 2003 , Kim et al. 2008 , Herrid et al. 2011 , Jahnukainen et al. 2011 , Hermann et al. 2012 , Zeng et al. 2012 led us believe this approach could be applied to the dog model.
Previously, we demonstrated that canine SSC can be transplanted successfully, that they can reestablish regions of normal spermatogenesis, and that they can generate mature donor-derived sperm in a host testis (Kim et al. 2008) . In that study, unfractionated seminiferous tubule cells were transplanted to a donor testis without enrichment, culture, or genetic manipulation. In order to exploit SSC transplantation as a viable approach to canine transgenesis, the efficiencies of SSC collection, gene transfer, engraftment, and donor sperm production will have to be optimized. Ideally, this may require clonal expansion of lines of transgenic SSC to achieve sufficient cell numbers and genetic homogeneity to guarantee a high level of transgenic sperm production and thus a practical ratio of transgenic to wild-type offspring. Here, we extended the previous findings by developing and assessing methods to isolate, culture, and genetically manipulate canine SPG. We then tested whether or not engraftment potential is maintained after these manipulations. Based on the rich data available on SPG markers in rodents and other animals, we were able to identify similar antigens and mRNAs that uniquely identified SPG and their progeny in canine testis. Several of these markers, including VASA, PLZF, DAZL, UCHLI, and AP180, were detectable, using commercially available antibodies, in prepubertal gonocytes, adult SPG, and cultured SPG. These antibodies facilitated tracking SPG through isolation and culture. Interestingly, five cell surface molecules (GFRA1, GPR125, ITGA6, ITGB1, and a-D-N-acetyl-galactosamine), which have been useful for flow cytometry-based enrichment of SPG from other species, were either undetectable or nonspecific for canine SPG. In the absence of a useful surface marker, we exploited a differential matrix affinity method for enrichment of canine SPG from prepubertal testis to 70% purity. The identity of this population was confirmed by the co-enrichment of mRNAs for 11 wellestablished SPG-specific genes. Lentiviral transduction of the enriched SPG yielded about 9% reporter-positive cells. Thus, it is now possible to prepare and cryopreserve a population of 0.5-1!10 6 70% pure canine SPG with 9% lentiviral marking from an average-sized prepubertal dog.
When cultured under the optimal conditions established for mice, the enriched canine SPG persisted as VASAC cells for several weeks. Under these conditions, some cells remain positive for several markers of SPG, including VASA, DAZL, UCHL1, AP180, and PLZF, suggesting that they may retain their SSC phenotype in culture. However, most of the VASA-positive cells lost expression of other primitive markers, suggesting loss of the SSC phenotype. Furthermore, there was no evidence of expansion of germ-line cells. The standard methods used by mouse SSC investigators of serially passaging clumps of rounded cells led to loss of SPG markers, as did trypsin-mediated or manual passage of the cells. Extensive testing of culture conditions did not reveal any advantage conferred by addition of feeder cells, matrix components, or other growth factors reported to enhance self-renewal divisions of mouse SSC. Thus, while canine SPG can be maintained in culture for weeks, conditions for expansion remain to be established. For the most part, these results parallel those reported from other large animal spermatogonial cell cultures. Short-term expansions of germ-line cells with SPG markers reported for human (He et al. 2010) , pig (Kuijk et al. 2009) , and bovine (Aponte et al. 2008) suggest that large animal SSC lines may soon be possible. However, in no case, has a stable line of SSC been reported from a large animal.
We have demonstrated, for the first time in dogs, that transplantation of transgenic SPG can lead to engraftment in a host testis and transmit the transgene to mature spermatozoa. This extends the findings in our previous study (Kim et al. 2008) , establishing engraftment of unfractionated, un-manipulated canine testis cells. In addition to the changes in donor cell manipulation, this study significantly changed the preconditioning regimen for host testes. In the first study, a fractionated dose of 9 Gy, 8 weeks before transplantation was used to eliminate endogenous stem cells. While this regimen was consistent with those used successfully in other large animals (Kim et al. 2006 , Herrid et al. 2009 , Jahnukainen et al. 2011 , Zeng et al. 2012 , it may have delivered too high a dose for the dog, as testis size, sperm count, and libido did not recover and sperm had to be recovered from the epididymis. Therefore, we reduced the irradiation dose to 3 Gy in this study. The lower radiation dose used resulted in complete recovery of libido, testis size, spermatogenesis, and sperm count. However, most of the recovery was undoubtedly from endogenous SSC that escaped the preconditioning, possibly inhibiting donor engraftment. The typical interval of several weeks between irradiation and transplant is based on the logic that tissue damage and inflammation caused by irradiation will interfere with homing of stem cells to their niche (Herrid et al. 2011) . However, there is not a compelling body of empirical data to confirm this. Arguably, disruption of the tissue might actually facilitate entry of the SSC to their niche by disturbing the Sertoli cell tight junctions that block entry to that niche (Takashima et al. 2011) . Hematopoietic stem cell homing to bone marrow is actually enhanced, not blocked, by local irradiation 24-h before infusion of the cells (Bastianutto et al. 2007 ). Thus, we used a single dose of 3 Gy, immediately before transplant. The optimal preconditioning regimen probably lies between those of our two studies.
By our calculation, the enriched and genetically modified SSC used here engrafted almost as well as did the un-enriched, untreated canine cells of our previous study. Based on histology, only a 5-15% recovery of spermatogenesis was observed in the first study, after 9 Gy of total irradiation. This was supported by about a 10% of normal sperm count. Thus, the observed 20% donor sperm represented about 2% of normal sperm production. In contrast, after a 3 Gy dose in this study, both histology and sperm count were normal, indicating a 100% recovery of spermatogenesis. Thus, the 1% donor sperm generated in these animals represented 1% of normal total germ cell activity and sperm production. As a large fraction of endogenous SSC survived the present 3 Gy preconditioning, it is also likely that these cells inhibited homing and engraftment of donor cells, either by physical exclusion or by homeostatic signaling mechanisms that regulate self-renewal (Caires et al. 2010 (Caires et al. , 2012 . From this comparison, we conclude that the level of donor engraftment in these two studies was similar, in spite of differences in preconditioning of the recipient tissue or isolation and manipulation of the donor cells. Similar studies with other large animals have yielded variable levels of donor sperm production (Honaramooz et al. 2003 , Izadyar et al. 2003 , Herrid et al. 2009 , Jahnukainen et al. 2011 , Hermann et al. 2012 , Zeng et al. 2012 , ranging from !1% to as high as 30% in sheep (Herrid et al. 2009 ).
The relatively low donor sperm levels observed here must be improved before canine SSC transplantation can be exploited as a practical approach for transgenesis. Optimization of the preconditioning regimen may yield a large improvement. Another area worthy of improvement may be immune compatibility. In this study, no attempt was made to match host and donor. The blood-testis barrier, which protects developing germ cells in the tubule lumen from immune surveillance, may not fully protect SSC. These cells reside outside the barrier formed by Sertoli cell tight junctions. However, there is also some degree of immune privilege outside the barrier, as immunologically unmatched SSC transplants in bull (Izadyar et al. 2003) , goat (Honaramooz et al. 2003) , pig (Mikkola et al. 2006) , as well as dog (Kim et al. 2008 ) have led to engraftment. Of note, unrelated SSC transplants in bulls yield significantly lower levels of engraftment than autologous transplants (Izadyar et al. 2003) , suggesting that work on this point might help improve efficiency. The importance of donor/ host interactions for canine SSC transplants remains to be determined.
Finally, establishment of culture conditions for true clonal expansion of canine SSC, such as is routine in mice, will also be extremely useful. A uniform clone of transgenic SSC would yield a greater than tenfold increase in the percent of transgenic cells over a primary transduction efficiency of 9%. It would also facilitate unlimited expansion, a 100-fold increase in the number of total SSC injected, would not exceed the cell numbers injected in our first study. It would also facilitate selection confirmation and expansion of low-frequency events, such as homologous recombination, before transplantation. All these factors will greatly affect the level of transgenic sperm production, and hence, the efficiency of generating transgenic offspring. A major obstacle to expansion of canine SSC may be speciesspecific qualities of self-renewal regulation. First, the available non-canine growth factors used in this study may not be fully compatible with the canine receptors. Secondly, canine SSC may utilize one or more alternative signaling pathways not observed in mice. With these caveats in mind, we are presently exploring both the production of canine growth factors, particularly GDNF, and genetic manipulation of canine SSC to bypass the requirement for GDNF (Lee et al. , 2009 .
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